The Future of Finance is Listening

biotech

882: The Chronic Door Opener | Brianna Gerber, CFO, ChromaDex

When Brianna Gerber tells us that during earnings season at Mattel, Inc., she was once known as the investor relations person most likely to be “knocking on doors,” we can’t help but want to learn more about her IR tour of duty at the toy giant.   “I’d be calling on the marketing team and…
Listen to the Episode Below (00:47:39)
Apple PodcastsGoogle PodcastsPlayer EmbedShare Leave a ReviewListen in a New WindowDownloadSoundCloudStitcherSubscribe on AndroidSubscribe via RSSSpotifyWhere to ListenYoutubeLinkedInLinkedIn

802: Making an Industry Lane Change | Mike Catelani, CFO, Anixa Biosciences, Inc.

When Mike Catelani seeks to identify the objectives and career milestones that have helped to advance him into the ranks of Bay Area biotech CFOs, he mentions that although he had a deep interest in biology during his high school years, upon entering college he decided to swap out a biology curriculum for an accounting…
Listen to the Episode Below (00:53:31)
Apple PodcastsGoogle PodcastsPlayer EmbedShare Leave a ReviewListen in a New WindowDownloadSoundCloudStitcherSubscribe on AndroidSubscribe via RSSSpotifyWhere to ListenYoutubeLinkedInLinkedIn

796: Gene Editing’s Next Frontier | Elaine Sun, CFO, Mammoth Biosciences

Having grown accustomed to charting the careers of our finance leader guests from their early professional days up through their entry into the CFO office, we did not change course for Elaine Sun, an accomplished investment banker turned finance leader who last month stepped into her third successive finance chief position at Mammoth Biosciences of…
Listen to the Episode Below (00:47:34)
Apple PodcastsGoogle PodcastsPlayer EmbedShare Leave a ReviewListen in a New WindowDownloadSoundCloudStitcherSubscribe on AndroidSubscribe via RSSSpotifyWhere to ListenYoutubeLinkedInLinkedIn

782: When Operations Came First | Lou Arcudi, CFO, Amolyt Pharma

To those well familiar with the career milestones that typically mark the path to the CFO office, Lou Arcudi’s resume at first may appear to be upside down. Or at least it could be said that the same operational projects and roles that frequently populate the tops of the resumes of aspiring CFOs are instead…
Listen to the Episode Below (01:08:41)
Apple PodcastsGoogle PodcastsPlayer EmbedShare Leave a ReviewListen in a New WindowDownloadSoundCloudStitcherSubscribe on AndroidSubscribe via RSSSpotifyWhere to ListenYoutubeLinkedInLinkedIn

745: Origins of a Comeback Therapy | Troy Ignelzi, CFO, Karuna Therapeutics

"You can achieve greatness and success no matter how humble your beginnings. Always give the best that you can contribute based on your skill set and surround yourself with the right people." –Troy Ignelzi, CFO, Karuna Therapeutics Troy Ignelzi’s CFO career is rooted in an unlikely place. In fact, some might describe it as the…
Listen to the Episode Below (00:45:24)
Apple PodcastsGoogle PodcastsPlayer EmbedShare Leave a ReviewListen in a New WindowDownloadSoundCloudStitcherSubscribe on AndroidSubscribe via RSSSpotifyWhere to ListenYoutubeLinkedInLinkedIn

699: The Return of Jimmy Lai | Jimmy Lai, CFO, Acepodia

When Acepodia CEO Sonny Hsiao began developing a list of candidates to fill the chief financial officer role at the biotechnology company that he had cofounded, it may have surprised some to see Jimmy Lai make the list. Certainly, this was not due to any U.S. markets void on Lai’s resume—to the contrary, he had…
Listen to the Episode Below (00:40:10)
1x
0:00
00:40:10
Apple PodcastsGoogle PodcastsPlayer EmbedShare Leave a ReviewListen in a New WindowDownloadSoundCloudStitcherSubscribe on AndroidSubscribe via RSSSpotifyWhere to ListenYoutubeLinkedInLinkedIn

689: Be the Bridge | Terry Coelho, CFO, BioDelivery Sciences International (BDSI)

Within 4 months of her 2019 arrival inside BDSI’s CFO office, Terry Coelho had spearheaded a product acquisition and managed a successful equity raise—two finance milestones that would produce generous sales tailwinds for the specialty pharmaceutical firm.   BDSI would experience 100% net sales growth in 2019, followed by 40% net sales growth in 2020. …
Listen to the Episode Below (00:49:00)
Apple PodcastsGoogle PodcastsPlayer EmbedShare Leave a ReviewListen in a New WindowDownloadSoundCloudStitcherSubscribe on AndroidSubscribe via RSSSpotifyWhere to ListenYoutubeLinkedInLinkedIn

669: Transactions, Trades, and Treatments | Ozan Pamir, CFO, 180 Life Sciences

We seldom hear a finance leader tell us that they took a pass on a promotion early in their careers, so when CFO Ozan Pamir told us that as a 25-year-old associate he had turned down a vice president position with Echelon Wealth Partners, a Canadian investment banking firm that he had been with for…
Listen to the Episode Below (00:38:16)
Apple PodcastsGoogle PodcastsPlayer EmbedShare Leave a ReviewListen in a New WindowDownloadSoundCloudStitcherSubscribe on AndroidSubscribe via RSSSpotifyWhere to ListenYoutubeLinkedInLinkedIn

666: When Vision Is the Plus Multiplier | Manmeet Soni, CFO, Reata Pharmaceuticals

It’s a phrase that has historically never roamed far beyond the corridors of pharmaceutical companies, but now—thanks to COVID 19—the term “clinical trials” has entered the vocabulary of the public at large. Perhaps at no time in history have the “trials” that pharma companies use to generate data on the safety of a particular drug, vaccine,…
Listen to the Episode Below (00:41:57)
Apple PodcastsGoogle PodcastsPlayer EmbedShare Leave a ReviewListen in a New WindowDownloadSoundCloudStitcherSubscribe on AndroidSubscribe via RSSSpotifyWhere to ListenYoutubeLinkedInLinkedIn

661: Finding Your Finance Port of Entry | Dan Stokely, CFO, Ampio Pharmaceuticals

Thinking back to his days as a charter boat captain off the coast of Point Loma, San Diego, Dan Stokely marvels at the responsibilities that he shouldered as a young adult. Serving a mix of customers, Stokely would routinely welcome on board groups of small business owners, executives, and doctors before setting off to sea on…
Listen to the Episode Below (01:05:36)
Apple PodcastsGoogle PodcastsPlayer EmbedShare Leave a ReviewListen in a New WindowDownloadSoundCloudStitcherSubscribe on AndroidSubscribe via RSSSpotifyWhere to ListenYoutubeLinkedInLinkedIn

653: From Real Estate to the Immune System | Chad Cohen, CFO, Adaptive Biotechnologies

Of all of the business discussions that Chad Cohen has had over the years, few are likely as memorable as the 20-second conversation he had with Zillow CEO Spencer Rascoff about midway into his 9-year career stint with the online real estate company. Cohen joined Zillow back in 2006 as corporate controller, a position that…
Listen to the Episode Below (00:45:53)
Apple PodcastsGoogle PodcastsPlayer EmbedShare Leave a ReviewListen in a New WindowDownloadSoundCloudStitcherSubscribe on AndroidSubscribe via RSSSpotifyWhere to ListenYoutubeLinkedInLinkedIn

648: A Life Sciences Angler Casts a Sturdy Line | Bill Adams, CFO, NervGen Pharma

It’s a familiar sequence: A strong-minded investor musters the will to lead and steps into the CEO office determined to revitalize a struggling technology company and put it back on the growth track. For Bill Adams, this swift turn of events occurred only a year into his first industry stint as a corporate controller—a career…
Listen to the Episode Below (00:45:12)
Apple PodcastsGoogle PodcastsPlayer EmbedShare Leave a ReviewListen in a New WindowDownloadSoundCloudStitcherSubscribe on AndroidSubscribe via RSSSpotifyWhere to ListenYoutubeLinkedInLinkedIn